Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$0.3 - $1.31 $16,284 - $71,108
-54,281 Reduced 97.17%
1,583 $0
Q1 2022

May 11, 2022

SELL
$0.61 - $1.84 $3,089 - $9,317
-5,064 Reduced 8.31%
55,864 $77,000
Q4 2021

Feb 10, 2022

SELL
$1.16 - $2.74 $15,394 - $36,362
-13,271 Reduced 17.89%
60,928 $73,000
Q3 2021

Nov 12, 2021

BUY
$2.62 - $5.43 $194,401 - $402,900
74,199 New
74,199 $195,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.